Transcode Therapeutics : Has Regained Compliance With Minimum Bid Price Requirement Set Forth in Nasdaq Listing Rule 5550(a)(2)
Transcode Therapeutics:已恢復符合納斯達克5550(a)(2)上市規則中規定的最低買盤價格要求。
Transcode Therapeutics : Has Regained Compliance With Minimum Bid Price Requirement Set Forth in Nasdaq Listing Rule 5550(a)(2)
Transcode Therapeutics:已恢復符合納斯達克5550(a)(2)上市規則中規定的最低買盤價格要求。
譯文內容由第三人軟體翻譯。